GlassScriptPhysician profile
Tushar Garg
NPI 1184104218
$1,848.63
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.72 · 2021: $181 · 2022: $1,629.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,071.00 | 2022 | |
| Siemens Medical Solutions USA, INC. | $461.96 | 2022 | |
| Boston Scientific Corporation | $95.78 | 2022 | |
| Pfizer INC. | $45.30 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $42.60 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $32.45 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.39 | 2021 | |
| Genentech, INC. | $19.72 | 2019 | |
| Genentech USA, INC. | $19.00 | 2019 | |
| Merck Sharp & Dohme LLC | $15.46 | 2021 | |
| Glaxosmithkline, LLC. | $14.97 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tushar Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.